123 iodine

Small moleculeexperimental

IODINE I-123 is a radioactive isotope of iodine used in nuclear medicine imaging, including single photon emission computed tomography (SPECT) and X-ray computed tomography (X-Ray CT) scans. Iodine-123 is usually supplied as sodium iodide (NaI) and hypoiodite (OI−) in dilute sodium hydroxide solution, at high isotopic purity. 123I is the most suitable isotope of iodine for the diagnostic study of thyroid diseases. The half-life of approximately 13.13 h (hours) is ideal for the 24-h (hour) iodine uptake test and 123I has other advantages for diagnostic imaging thyroid tissue and thyroid cancer metastasis. The iodine is taken up by the thyroid gland and/or cancer metastasis and a gamma camera is used to functional images of the thyroid for diagnosis. Quantitative measurements of the thyroid can be performed to calculate the iodine uptake (absorption) for the diagnosis of hyperthyroidism and hypothyroidism. This is administered to a patient in capsule form, by intravenous injection, or in a drink. — NCATS

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
1
Phase 4
0

Earliest trial started May 1, 2013 (NCT02418247)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetRadiodepletion

    radiodepletion

Chemistry & pharmacology

Loading structure…

SMILES

[123I][123I]
Mol. weight
245.811195888 g/mol

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 123i−
  • 123i−
  • 123 iodine
  • i123
  • i 123
  • i 123
  • i-123
  • i-123
  • iodide i-123
  • iodide i-123
  • iodide ion i-123
  • iodide ion i-123
  • iodine 123
  • iodine 123
  • iodine-123
  • iodine-123
  • iodine-123

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02418247Phase 2/Phase 3 (Phase 3)May 1, 2013National Cancer Center, Korea
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Cancer Center, KoreaGovernment1112013
1 organizations
Page 1 / 1